Department of Pharmaceutical Analysis, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, PR China.
Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, PR China.
Pharm Dev Technol. 2020 Jan;25(1):68-75. doi: 10.1080/10837450.2019.1671864. Epub 2019 Oct 1.
To improve the aqueous solubility and the oral bioavailability of a poorly water-soluble biologically active pentacyclic triterpenoid, ursolic acid (UA), ursolic acid-phospholipid complex (UA-PC) was prepared using solvent-assisted grinding method which is green and simple. The phospholipid complex was characterized by differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), scanning electron microscope (SEM), and transmission electron microscope (TEM), which confirmed the formation of the phospholipid complex. Specifically, compared with free UA, the formulation demonstrated over 276-fold higher aqueous solubility of UA and exhibited faster dissolution rate and higher cumulative dissolution percentages. Finally, the oral bioavailability of the prepared UA-PC was evaluated using Sprague-Dawley (SD) rats. Compared with free UA, the UA-PC exhibited considerable enhancement in the bioavailability with an increase in (183.80 vs 68.26 μg/l) and AUC (878.0 vs 212.1 μg·h/l), which was consistent with the in vitro results. This enhancement was attributed to the improvement of solubility and dissolution in vitro. Therefore, the method of solvent-assisted grinding appears to be an efficient approach for the preparation of UA-PC, and the prepared UA-PC showed a promising potential to overcome the limitation of poor oral bioavailability associated with low water solubility.
为了提高一种水溶性差的生物活性五环三萜熊果酸(UA)的水溶性和口服生物利用度,采用绿色简单的溶剂辅助研磨法制备了熊果酸-磷脂复合物(UA-PC)。通过差示扫描量热法(DSC)、粉末 X 射线衍射(PXRD)、扫描电子显微镜(SEM)和透射电子显微镜(TEM)对磷脂复合物进行了表征,证实了磷脂复合物的形成。具体而言,与游离 UA 相比,制剂中 UA 的水溶解度提高了 276 倍以上,显示出更快的溶解速率和更高的累积溶解百分比。最后,采用 Sprague-Dawley(SD)大鼠评估了制备的 UA-PC 的口服生物利用度。与游离 UA 相比,UA-PC 的生物利用度有了显著提高,AUC(878.0 与 212.1μg·h/l)和 Cmax(183.80 与 68.26μg/l)均有所增加,这与体外结果一致。这种增强归因于体外溶解度和溶解度的提高。因此,溶剂辅助研磨法似乎是制备 UA-PC 的有效方法,并且所制备的 UA-PC 显示出克服低水溶性相关的口服生物利用度差的限制的有希望的潜力。